Efficacy and safety of direct-acting antiviral therapy in previous hard-to-treat patients with recurrent hepatitis C virus infection after liver transplantation: a real-world cohort. [electronic resource]
- Drug design, development and therapy 2017
- 2131-2138 p. digital